Rheumatology Patient Care
A doctor working with a patient

A Personalized Approach to Treatment

Our division is internationally recognized for excellence in the diagnosis and management of rheumatic and musculoskeletal diseases.

Clinicians in the Division of Rheumatology treat a vast array of conditions, including rheumatoid arthritis, lupus, antiphospholipid syndrome, scleroderma, vasculitis, Sjogren's syndrome, psoriatic arthritis, ankylosing spondylitis, myositis, and gout. With over 40 physicians and advanced practice providers delivering inpatient and outpatient care, our Division is one of the largest in the country. In addition to University of Michigan Health and the Ann Arbor VA Hospital, rheumatology patients are seen in several clinics located in Ann Arbor, Brighton and Northville.

For our clinic information, specialty clinics, procedure information and more, please visit the Rheumatology section on UofMHealth.org
Find a Doctor

Find a doctor who meets your needs

Find a Clinic

Find a clinic near you

Patient & Visitor Guide

Find additional information and resources for patient and visitors

For Referring Providers

Connect with M-LINE for referral and consultation information

Rheumatology Care at U-M Health
Treating a Range of Rheumatic Diseases

We treat a wide array of rheumatic diseases at our clinics with state-of-the-art multidisciplinary care. Our dedicated team ensures each patient receives a personalized treatment plan designed for optimal long-term outcomes.

Rheumatology Services
Featured News & Stories See all news Translational immunology lab space ribbon-cutting ceremony
Department News
Collaborative Lab Space Fuels Translational Immunology Research
On Wednesday, October 30, 2024, a ribbon-cutting ceremony was held to celebrate and officially mark the opening of the new Translational Immunology Research lab space at the North Campus Research Complex.
 microscope
Health Lab
Antibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis
Using the Ab38 antibody to target the CD38 enzyme could be a new gateway to treat and prevent fibrosis for patients with systemic sclerosis.
 microscope
Health Lab
Targeting and blocking sCD13 protein could lead to systemic sclerosis treatment
Targeting and blocking the sCD13 protein from interacting with the B1R protein can pave the way for new fibrosis and systemic sclerosis treatments.
 blood vial blue yellow
Health Lab
Could targeting metabolism treat blood clots in antiphospholipid syndrome? 
A research team is investigating how metabolism – the process by which cells turn sugars, fats and proteins into energy – is used to make NETs in regards to antiphospholipid syndrome.
 ACR Journals on Air Podcast with Dr. Ray Zuo
Research News
ACR Journals on Air Podcast: Calprotectin in Antiphospholipid Syndrome
Dr. Yu (Ray) Zuo recently sat down with podcast host, Victoria Shanmugam, MBBS, MRCP, CCD, to discuss whether calprotectin can be a functional biomarker for those with APS thrombocytopenia and what the future holds for this study’s conclusions.
 2024 CARRA-AF Grant Awardee, Dr. Jacqueline Madison
Research News
2024 CARRA-Arthritis Foundation Research Grant Awardee, Dr. Jacqueline Madison
Jacqueline Madison, MD, Assistant Professor in the Division of Rheumatology and member of the APS Research Labs, has been awarded the CARRA-Arthritis Foundation Research Grant.